Zobrazeno 1 - 10
of 24
pro vyhledávání: '"James S. Foulke"'
Autor:
Parul Agrawal, Anthony L. DeVico, James S. Foulke, Jr., George K. Lewis, Marzena Pazgier, Krishanu Ray
Publikováno v:
Cell Reports, Vol 29, Iss 1, Pp 176-186.e4 (2019)
Summary: Analyses of HIV-1 envelope (Env) binding to CD4, and the conformational changes the interactions induce, inform the molecular mechanisms and factors governing HIV-1 infection. To address these questions, we used a single-molecule detection (
Externí odkaz:
https://doaj.org/article/7d6c01ebc57c4dc69bff09b248636809
Autor:
George K. Lewis, Mileidy Gonzalez, Anthony L. DeVico, Meron Mengistu, John L. Spouge, Robert C. Gallo, James S. Foulke, Thomas A. Blanpied, Ai-Hui Tang
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance A complete picture of HIV antigenicity during early replication is needed to elucidate the full range of options for controlling infection through humoral immunity. The HIV envelope protein, gp120, experiences key structural rearrangemen
Autor:
Said Hassounah, Nhut Le, Alonso Heredia, Yingshan Han, Robert R. Redfield, Mark A. Wainberg, Joseph Bryant, Charles E. L. B. Davis, Juan C. Zapata, James S. Foulke, Sandra Medina-Moreno
To compare the effectiveness of HIV integrase inhibitor monotherapy between raltegravir and dolutegravir as an approach to simplify therapy.We evaluated and compared the efficacy of 20 week monotherapy with dolutegravir or raltegravir in humanized mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3eeedc66f9c0f301ff7c95945bc0e46
https://europepmc.org/articles/PMC5890682/
https://europepmc.org/articles/PMC5890682/
Autor:
Nhut Le, Alonso Heredia, Anthony L. DeVico, Robert R. Redfield, Ranajit Pal, Olga Latinovic, James S. Foulke, Marvin S. Reitz
Publikováno v:
AIDS. 25:1232-1235
CCR5 serves as the main coreceptor for the predominantly transmitted and most persistent HIV-1, the R5 strains. Maraviroc (MVC) is the only licensed CCR5 inhibitor [1, 2]. CCR5 antibodies PRO 140 and HGS004 have significantly reduced HIV-1 RNA in cli
Autor:
James S. Foulke, Juan M. Zapata, Sandra Medina-Moreno, Ying-Shan Han, Said Hassounah, Charles B. Davis, Nhut Le, Alonso Heredia
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 77:64-64
Publikováno v:
Journal of Leukocyte Biology. 79:378-387
Local production of macrophage inflammatory protein-1β (MIP-1β), a β-chemokine that blocks human immunodeficiency virus type 1 (HIV-1) entry into CD4+ CC chemokine receptor 5+ target cells, may be a significant factor in resistance to HIV-1 infect
Autor:
Marzena Pazgier, James E. Robinson, Yongping Yang, George K. Lewis, Neelakshi Gohain, Peter D. Kwong, Robin Flinko, Roberta Kamin-Lewis, Tongyun Liu, Wensheng Huang, James S. Foulke, Chih-chin Huang, Marie Pancera, Lei Yu, Jason S. McLellan, Yongjun Guan, Robert K. Louder, Young Do Kwon, Priyamvada Acharya, Mohammad M. Sajadi, Baoshan Zhang, William D. Tolbert, Xueji Wu, Anthony L. DeVico, Loïc Martin, Timothy S. Luongo
Publikováno v:
Journal of Virology
Journal of Virology, American Society for Microbiology, 2014, 88 (21), pp.12895-12906. ⟨10.1128/JVI.02194-14⟩
Journal of Virology, 2014, 88 (21), pp.12895-12906. ⟨10.1128/JVI.02194-14⟩
Journal of Virology, American Society for Microbiology, 2014, 88 (21), pp.12895-12906. ⟨10.1128/JVI.02194-14⟩
Journal of Virology, 2014, 88 (21), pp.12895-12906. ⟨10.1128/JVI.02194-14⟩
The RV144 vaccine trial implicated epitopes in the C1 region of gp120 (A32-like epitopes) as targets of potentially protective antibody-dependent cellular cytotoxicity (ADCC) responses. A32-like epitopes are highly immunogenic, as infected or vaccina
Autor:
Charles E. L. B. Davis, Mark A. Wainberg, Lai-Xi Wang, Robert R. Redfield, Marvin S. Reitz, Nhut Le, Alonso Heredia, James S. Foulke
Global programs expanding access to antiretroviral treatments represent a highly successful public health intervention [1]. To date, >6 million persons living with human immunodeficiency virus type 1 (HIV-1) infection have received antiviral treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13164473050a62604783ddd59716f7a
https://europepmc.org/articles/PMC3836462/
https://europepmc.org/articles/PMC3836462/
Autor:
James S. Foulke, Jeffrey L. Kelly, Gayle L. Canter, James J. Anderson, John T. Turner, Brenda B. Uratani, J S Lampel, Michael B. Dimock
Publikováno v:
Applied and Environmental Microbiology. 60:501-508
A bacterial endophyte was engineered for insecticidal activity against the European corn borer. The cryIA(c) gene from Bacillus thuringiensis subsp. kurstaki was introduced into the chromosome of Clavibacter xyli subsp. cynodontis by using an integra
Autor:
Robert R. Redfield, Clara Lehmann, Marvin S. Reitz, Gerd Fätkenheuer, Olga Latinovic, James S. Foulke, Nhut Le, Alonso Heredia
R5 HIV-1 strains resistant to the CCR5 antagonist Maraviroc (MVC) can use drug-bound CCR5. We demonstrate that MVC-resistant HIV-1 exhibits delayed kinetics of coreceptor engagement and fusion during drug-bound versus free CCR5 infection of cell line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319e003e0a30fbde135ca2af384c59da
https://europepmc.org/articles/PMC3039059/
https://europepmc.org/articles/PMC3039059/